Cohn on psychedelics: Telling the FDA to fast-track certain approvals risks patient safety and trust
April 29, 2026
409
42
3
11.00%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Tim Miller Episodes Around April 29, 2026
See what was published immediately before and after this episode.
2:58Now PlayingCohn on psychedelics: Telling the FDA to fast-track certain approvals risks patient safety and trust
YouTube Description
as posted by the channelPsychedelics could be a breakthrough for mental health.
But telling the FDA to fast-track certain approvals risks both patient safety and trust in the system.
Jonathan Cohn takes a closer look. #short
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.